Med Into Grad (MIG) was a Ph.D. training program in Translational Cancer Diagnostics and Therapeutics Research for Bioengineers and Biophysicists that integrated cancer biology, clinical medicine, translational research, and bioengineering. The MIG was sponsored by the Howard Hughes Medical Institute and existed from 2006-2015. As partners, Rice University and The University of Texas MD Anderson Cancer Center developed a unique training program for bioengineering graduate students that integrated: courses in cancer biology, clinical medicine, bioengineering and translational research; unique internship in clinical cancer care and translational research; and jointly mentored interdisciplinary Ph.D. projects. The goal of the MIG training program was to develop professionals with the expertise to make breakthroughs needed to reduce the incidence and mortality of cancer.